-
-
-
-
-
-
-
Avenue Therapeutics Announces that the FDA is Still Reviewing Its NDA Resubmission for IV Tramadol
-
-
-
-
-
-
-
Avenue Therapeutics (ATXI) PT Raised to $12 at Oppenheimer
-
-
-
-
-
-
-
Avenue Therapeutics Announces New Drug Application for IV Tramadol Accepted for Review by FDA
14,982 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

